Genmab is driving the next generation of antibody-based medicines to transform the lives of patients with cancer and other serious diseases.

At Genmab, patients are our fundamental focus. From the way we design and conduct our clinical trials to the way we deliver our medicines—each step in the process is guided by what is best for the patient. Why? Because the most important thing about our medicines is the people who use them.

We believe women with gynecologic malignancies deserve better, and we’re driven to deliver it. Through next-generation antibody-based therapies, we’re aiming to target gynecologic cancer and bring hope to those who need it most.

Our work in cervical cancer is grounded in collaboration with the advocates and providers who know the gynecologic cancer community best. Today, our commitment remains stronger than ever as we continue to collaborate and drive meaningful clinical progress.